The WHO had listed the AstraZeneca-Oxford COVID-19 vaccine for emergency use.
The World Health Organization (WHO) listed the AstraZeneca-Oxford COVID-19 vaccine for emergency use, widening access to the relatively-inexpensive shot in the developing countries.
WHO Director-General Tedros Adhanom Ghebreyesus on Monday told a news briefing that they had all the pieces in place for the rapid distribution of COVID-19 vaccines, but they still need to scale up production.
Tedros also said that they continued to call for COVID-19 vaccine makers to submit their dossiers to the World Health Organization for review at the same time as they submitted them to regulators in high-income countries.
READ ALSO: LGUs, Private Sector To Advance Payment For AstraZeneca COVID-19 Vaccine Doses On February 24
A WHO statement stated that it had approved the COVID-19 vaccine as produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.
In a separate statement announcing the approval, AstraZeneca stated that in the first half of 2021, it was hoped that more than 300 million COVID-19 vaccine doses would be made available to 145 countries through COVAX Facility, pending supply and operational challenges.
The listing by the UN health agency came days after a World Health Organization panel provided interim recommendations on the COVID-19 vaccine, saying that two COVID-19 vaccine doses with an interval of around 8-12 weeks should be given to all adults and these vaccines could also be used in countries with the South African COVID-19 variant as well.
The World Health Organization’s review found that the Astrazeneca-Oxford COVID-19 vaccine met the “must-have” criteria for safety and its efficacy benefits outweighed its risks.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
